GlassScriptPhysician profile
Eric Sooyong Ahn
NPI 1841457652
$1,327.49
in general payments reported to CMS, 2019-2025
18 companies · $86.99 in 2025
The $86.99 reported for 2025 was less than what a typical Ophthalmic Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $299).
See the full distribution for Ophthalmic Plastic and Reconstructive Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $34.12 · 2020: $34.79 · 2021: $304 · 2022: $322 · 2023: $332 · 2024: $214 · 2025: $86.99.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $624 · Education: $8.45.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $624.16 |
| Education | $8.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $330.77 | 2022-2025 | |
| Horizon Therapeutics Plc | $234.71 | 2021-2022 | |
| Kowa Research Institute, INC. | $122.94 | 2022-2023 | |
| Allergan, INC. | $110.15 | 2021-2022 | |
| Merz North America, INC. | $94.75 | 2023 | Xeomin |
| Galderma Laboratories, L.P. | $87.86 | 2021-2024 | |
| Amgen INC. | $52.82 | 2024 | Tepezza |
| Abbott Laboratories | $51.82 | 2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $45.38 | 2020-2021 | |
| Aerie Pharmaceuticals, INC. | $43.91 | 2019-2020 | |
| Medtronic, INC. | $40.00 | 2022 | |
| Tarsus Pharmaceuticals, INC. | $29.43 | 2025 | Xdemvy |
| Sun Pharmaceutical Industries INC. | $24.82 | 2023 | Cequa |
| Revance Therapeutics, INC. | $21.05 | 2024 | Daxxify |
| Kala Pharmaceuticals, INC. | $14.93 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $12.43 | 2022 | |
| Alimera Sciences, INC. | $9.72 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Ahn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.